• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday

    1/26/24 10:30:51 AM ET
    $APPF
    $AVTR
    $AXP
    $BAH
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $APPF alert in real time by email

    U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.

    Shares of Booz Allen Hamilton Holding Corporation (NYSE:BAH) rose sharply during Friday’s session after the company reported better-than-expected third-quarter financial results, increased its quarterly dividend and raised FY24 guidance.

    Booz Allen Hamilton posted adjusted earnings of $1.41 per share, beating market estimates of $1.14 per share. The company’s quarterly sales came in at $2.57 billion versus expectations of $2.54 billion, according to data from Benzinga Pro.

    Booz Allen Hamilton shares jumped 13.2% to $145.90 on Friday.

    Here are some other big stocks recording gains in today’s session.

    • AppFolio, Inc. (NASDAQ:APPF) surged 25.7% to $219.23 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
    • Vera Therapeutics, Inc. (NASDAQ:VERA) gained 20.6% to $30.54. Raymond James analyst Steven Seedhouse upgraded Vera Therapeutics from Outperform to Strong Buy and raised the price target from $29 to $37.
    • eHealth, Inc. (NASDAQ:EHTH) jumped 19.8% to $6.70 after the company announced preliminary results for the fourth quarter.
    • Tellurian Inc. (NASDAQ:TELL) shares rose 16.6% to $0.6067 following a report suggesting the company hired Lazard to explore a possible sale.
    • Cipher Mining Inc. (NASDAQ:CIFR) climbed 11.8% to $2.64.
    • Lumen Technologies, Inc. (NASDAQ:LUMN) gained 11.2% to $1.5350 after the company announced that it entered into an amended and rested transaction support agreement with a group of creditors.
    • ESSA Pharma Inc. (NASDAQ:EPIX) gained 11% to $7.55.
    • Mereo BioPharma Group plc (NASDAQ:MREO) rose 10.5% to $4.0207.
    • Freedom Holding Corp. (NASDAQ:FRHC) gained 8.5% to $84.98 after the company announced the conclusion of an external review of allegations made in a short-seller report.
    • CleanSpark, Inc. (NASDAQ:CLSK) climbed 7.8% to $7.88.
    • Repligen Corporation (NASDAQ:RGEN) rose 7.3% to $199.07.
    • American Express Company (NYSE:AXP) climbed 7.2% to $201.61 after the company posted quarterly results and plans to increase the regular quarterly dividend by 17%.
    • Avid Bioservices, Inc. (NASDAQ:CDMO) rose 7.2% to $7.42.
    • First Financial Bankshares, Inc. (NASDAQ:FFIN) rose 6.9% to $32.29 after the company reported fourth-quarter financial results.
    • The Bancorp, Inc. (NASDAQ:TBBK) climbed 6.6% to $43.18 after the company reported better-than-expected fourth-quarter sales results.
    • Gentex Corporation (NASDAQ:GNTX) surged 6% to $33.74 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
    • Olin Corporation (NYSE:OLN) gained 6% to $54.89 following strong results.
    • Avantor, Inc. (NYSE:AVTR) rose 5.2% to $23.07 after Raymond James maintained an Outperform rating on the stock and raised its price target from $22.5 to $26.

     

    Now Read This: How To Earn $500 A Month From Pfizer Stock Ahead Of Q4 Earnings Print

    Get the next $APPF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APPF
    $AVTR
    $AXP
    $BAH

    CompanyDatePrice TargetRatingAnalyst
    Booz Allen Hamilton Holding Corporation
    $BAH
    4/1/2026$85.00Equal Weight
    Wells Fargo
    AppFolio Inc.
    $APPF
    3/26/2026$222.00Buy
    The Benchmark Company
    Mereo BioPharma Group plc
    $MREO
    3/23/2026Overweight → Neutral
    Analyst
    The Bancorp Inc
    $TBBK
    3/12/2026$66.00Overweight
    Piper Sandler
    Vera Therapeutics Inc.
    $VERA
    3/11/2026$88.00Peer Perform → Outperform
    Wolfe Research
    Avantor Inc.
    $AVTR
    3/6/2026$8.50Equal Weight → Underweight
    Barclays
    eHealth Inc.
    $EHTH
    2/26/2026$2.00Buy → Hold
    Craig Hallum
    Cipher Digital Inc.
    $CIFR
    2/9/2026$38.00Overweight
    Morgan Stanley
    More analyst ratings

    $APPF
    $AVTR
    $AXP
    $BAH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Edwards Murray Hamilton bought $29,320 worth of shares (1,000 units at $29.32) (SEC Form 4)

    4 - FIRST FINANCIAL BANKSHARES INC (0000036029) (Issuer)

    3/16/26 4:04:26 PM ET
    $FFIN
    Major Banks
    Finance

    Grp. Pres., Global Comm. Serv. Joabar Raymond bought $4,054 worth of shares (23 units at $176.26) and sold $12,257 worth of shares (40 units at $306.42) (SEC Form 4)

    4 - AMERICAN EXPRESS CO (0000004962) (Issuer)

    3/13/26 4:40:36 PM ET
    $AXP
    Finance: Consumer Services
    Finance

    Director Haney Geoff bought $43,770 worth of shares (1,500 units at $29.18), increasing direct ownership by 5% to 33,646 units (SEC Form 4)

    4 - FIRST FINANCIAL BANKSHARES INC (0000036029) (Issuer)

    3/13/26 12:11:47 PM ET
    $FFIN
    Major Banks
    Finance

    $APPF
    $AVTR
    $AXP
    $BAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026

    RADNOR, Pa., April 3, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2026 financial results before the market opens on Wednesday, April 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Daylight Time. To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A repl

    4/3/26 8:05:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Olin Corporation First Quarter 2026 Earnings Conference Call Announcement

    CLAYTON, Mo., April 2, 2026 /PRNewswire/ -- Olin Corporation (NYSE:OLN) announced today that on Friday, May 8, 2026, at 9:00 a.m. Eastern time, Olin's senior management will review the company's first quarter 2026 financial results. Our prepared remarks will be followed by a question-and-answer period. A press release, including financial statements and segment information, will be distributed after the market closes on Thursday, May 7, 2026, together with the associated slides.CONFERENCE CALL & WEBCAST DETAILSU.S. callers may access the conference toll-free by dialing (877) 883

    4/2/26 4:05:00 PM ET
    $OLN
    Major Chemicals
    Industrials

    American Express, Resy and Chef's Table Announce Expansive Partnership to Transform Culinary Storytelling Into Real-World Dining Experiences

    The collaboration kicks off this June with an intimate narrative-driven dinner series, followed by a culinary festival and an awards ceremony American Express, Resy and Chef's Table are embarking on a multi-year partnership that will extend the groundbreaking Netflix series into immersive programming for chef-obsessed diners and American Express® Card Members. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402962422/en/American Express, Resy, and Chef's Table kick off their expansive partnership this June with an intimate narrative-driven dinner series, followed by a culinary festival and an awards ceremony. The partnership

    4/2/26 9:00:00 AM ET
    $AXP
    Finance: Consumer Services
    Finance

    $APPF
    $AVTR
    $AXP
    $BAH
    SEC Filings

    View All

    SEC Form DEFA14A filed by Repligen Corporation

    DEFA14A - REPLIGEN CORP (0000730272) (Filer)

    4/2/26 4:14:08 PM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by Repligen Corporation

    DEF 14A - REPLIGEN CORP (0000730272) (Filer)

    4/2/26 4:13:00 PM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SCHEDULE 13G filed by Vera Therapeutics Inc.

    SCHEDULE 13G - Vera Therapeutics, Inc. (0001831828) (Subject)

    4/1/26 5:32:23 PM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APPF
    $AVTR
    $AXP
    $BAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Page Tyler

    4 - Cipher Digital Inc. (0001819989) (Issuer)

    4/2/26 9:38:47 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Kelly Patrick Arthur

    4 - Cipher Digital Inc. (0001819989) (Issuer)

    4/2/26 9:37:11 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Iwaschuk William

    4 - Cipher Digital Inc. (0001819989) (Issuer)

    4/2/26 9:37:58 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    $APPF
    $AVTR
    $AXP
    $BAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on Booz Allen Hamilton with a new price target

    Wells Fargo initiated coverage of Booz Allen Hamilton with a rating of Equal Weight and set a new price target of $85.00

    4/1/26 8:29:05 AM ET
    $BAH
    Professional Services
    Consumer Discretionary

    The Benchmark Company initiated coverage on AppFolio with a new price target

    The Benchmark Company initiated coverage of AppFolio with a rating of Buy and set a new price target of $222.00

    3/26/26 8:46:05 AM ET
    $APPF
    Computer Software: Prepackaged Software
    Technology

    Mereo BioPharma downgraded by Analyst

    Analyst downgraded Mereo BioPharma from Overweight to Neutral

    3/23/26 8:27:06 AM ET
    $MREO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APPF
    $AVTR
    $AXP
    $BAH
    Financials

    Live finance-specific insights

    View All

    Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026

    RADNOR, Pa., April 3, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2026 financial results before the market opens on Wednesday, April 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Daylight Time. To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A repl

    4/3/26 8:05:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Olin Corporation First Quarter 2026 Earnings Conference Call Announcement

    CLAYTON, Mo., April 2, 2026 /PRNewswire/ -- Olin Corporation (NYSE:OLN) announced today that on Friday, May 8, 2026, at 9:00 a.m. Eastern time, Olin's senior management will review the company's first quarter 2026 financial results. Our prepared remarks will be followed by a question-and-answer period. A press release, including financial statements and segment information, will be distributed after the market closes on Thursday, May 7, 2026, together with the associated slides.CONFERENCE CALL & WEBCAST DETAILSU.S. callers may access the conference toll-free by dialing (877) 883

    4/2/26 4:05:00 PM ET
    $OLN
    Major Chemicals
    Industrials

    Gentex Schedules First Quarter 2026 Earnings Release Date and Conference Call

    ZEELAND, Mich., March 31, 2026 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ:GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, fire protection technologies and consumer electronics, is pleased to announce that it will release its First Quarter 2026 financial results on Friday, April 24, before the market opens. The Company will host a conference call for the investment community at 9:30am ET to discuss the results. The call will also be available to the general public via a live audio webcast. Participants who wish to ask questions may register for the call at the following URL to receive the dial-in numbers and unique PIN: https://register-con

    3/31/26 8:00:00 AM ET
    $GNTX
    Auto Parts:O.E.M.
    Consumer Discretionary

    $APPF
    $AVTR
    $AXP
    $BAH
    Leadership Updates

    Live Leadership Updates

    View All

    Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

    BRISBANE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Jane Wright-Mitchell, Pharm.D., J.D., as Chief Legal Officer, effective immediately. "Jane has worked with Vera Therapeutics previously as a strategic legal consultant and brings a depth and breadth of experience in supporting companies through regulatory approvals, commercialization, and intellectual property management," said Marshall Fordyce, M.D., Founder and CEO of Vera Therapeutics. "As we near the potential launch of

    3/25/26 7:30:00 AM ET
    $PCVX
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lumen Technologies Announces Board Chair Transition, New Director Nominee and Executive Role Expansions

    Board Chair Mike Glenn and Director Hal Jones to Retire at 2026 Annual Meeting; General Kevin P. Chilton Named Next Chair Bain & Company Partner Michael Collins Nominated to Join Board Enhances Leadership Structure to Support Growth Phase of Transformation Lumen Technologies, Inc. ("Lumen") (NYSE: LUMN) today announced that Mike Glenn, Chair of Lumen's Board of Directors (the "Board"), and Hal Stanley Jones, a director and Chair of the Audit Committee, have advised the Board that they will retire and not stand for re-election at Lumen's 2026 Annual Meeting of Shareholders (the "Annual Meeting"). This press release features multimedia. View the full release here: https://www.businessw

    3/17/26 7:30:00 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Vera Therapeutics Appoints Christopher Hite to Board of Directors

    BRISBANE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christopher Hite, an accomplished executive with decades of corporate and financial strategy leadership experience in the biopharmaceutical sector, to Vera Therapeutics' Board of Directors. "It is a pleasure to welcome Chris to our Board of Directors at this exciting juncture in Vera Therapeutics' trajectory as we near the potential launch of our first-in-class dual BAFF/APRIL inhibitor for patients with IgA nephropathy," sa

    3/5/26 9:00:22 AM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APPF
    $AVTR
    $AXP
    $BAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Avid Bioservices Inc.

    SC 13G - Avid Bioservices, Inc. (0000704562) (Subject)

    12/13/24 10:53:25 AM ET
    $CDMO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Avid Bioservices Inc.

    SC 13G/A - Avid Bioservices, Inc. (0000704562) (Subject)

    11/14/24 7:53:01 PM ET
    $CDMO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by ESSA Pharma Inc.

    SC 13G/A - ESSA Pharma Inc. (0001633932) (Subject)

    11/14/24 7:32:27 PM ET
    $EPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care